Conrol group:placebo

4 trials

Sponsors

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, The Second People’s Hospital of Foshan, Affiliated Hospital of Zunyi Medical University, The West China Second Hospital of Sichuan University

Conditions

Heart failure with preserved ejection fractionconstipation in pregnancylymphedemarepeated implantation failure

Early Phase 1

Clinical effect of

RecruitingChiCTR2200062754

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicinerepeated implantation failure

Start: 2022-08-18Updated: 2023-04-12

Phase 1

Observation on the curative effect of dagglitazonein in the treatment of heart failure with preserved ejection fraction and its influence on hemodynamics

Active, not recruitingChiCTR2200063076

The Second People’s Hospital of FoshanHeart failure with preserved ejection fraction

Start: 2022-08-31Updated: 2023-04-12

Canceled by the investigator. A prospective clinical study of oral metformin in the treatment of secondary lymphedema

Active, not recruitingChiCTR2200063873

Affiliated Hospital of Zunyi Medical Universitylymphedema

Start: 2022-09-19Updated: 2023-04-17

Phase 3

Seamless design, multi-center, randomized, double-blind, placebo-controlled clinical trial of bifidobacteria tetra (live tablet) for constipation during pregnancy

Active, not recruitingChiCTR2300068849

The West China Second Hospital of Sichuan Universityconstipation in pregnancy

Start: 2023-03-01Updated: 2023-05-22